Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
University of Arizona
Medical College of Wisconsin
City of Hope Medical Center
Acepodia Biotech, Inc.
Stanford University
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
University of Kansas Medical Center
Fifth Affiliated Hospital, Sun Yat-Sen University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Anhui Provincial Hospital
University of Washington
SWOG Cancer Research Network
Shanghai Pudong Hospital
Loyola University
Zhejiang University
M.D. Anderson Cancer Center
Children's Oncology Group
Sabz Biomedicals
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Henan Cancer Hospital
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Children's Oncology Group
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins